Tsen‐Fang Tsai
National Taiwan University(TW)Far Eastern Memorial Hospital(TW)National Taiwan University Hospital(TW)UCB Pharma (Belgium)(BE)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Autoimmune Bullous Skin Diseases, Asthma and respiratory diseases, Autoimmune and Inflammatory Disorders Research
Most-Cited Works
- → Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials(2014)1,933 cited
- → Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial(2015)538 cited
- → Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial(2017)396 cited
- → Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 Induction(2008)347 cited
- → Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial(2017)337 cited
- → Trial of Spesolimab for Generalized Pustular Psoriasis